Chief Scientist of Proteros joins Hesperos
Dr. We are pleased to announce Dr. Torston Hoffmann joining the Hesperos team as Senior Consultant for Drug Discovery.
Dr. Hoffmann is currently the Chief Scientific Officer for Proteros biostructures in Munich, Germany. He is the the creator and inventor of Netupitant, an anti-emetic medicine for the preventive treatment of cancer-chemotherapy induced nausea and vomiting, approved by the FDA as Akynzeo© in 2014, and recommended since 2015 by the National Comprehensive Cancer Network, an alliance of 26 of the world's leading cancer centers.
Click to read his full bio on the Team page.